Clinical Trials on Type II Gaucher Disease in United Kingdom
Total 27203 results
-
SanofiActive, not recruitingGaucher's Disease Type III | Gaucher's Disease Type ICanada, Argentina, France, Italy, Japan, Russian Federation, Spain, Sweden, Turkey, United Kingdom
-
Cambridge University Hospitals NHS Foundation TrustMedical Research Council; National Institute for Health Research, United KingdomRecruitingGaucher Disease, Type III | Gaucher Disease, Type IUnited Kingdom
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited Kingdom, United States
-
University of California, San FranciscoDuke UniversityRecruitingWolman Disease | MPS IVA | Pompe Disease Infantile-Onset | Gaucher Disease, Type 2 | MPS VI | MPS I | Gaucher Disease, Type 3 | MPS II | Mps VIIUnited States
-
Genzyme, a Sanofi CompanyActive, not recruitingGaucher Disease Type 1 | Gaucher Disease Type 3Germany, United States, Japan, United Kingdom
-
Freeline TherapeuticsRecruitingGaucher Disease, Type 1Spain, Israel, United States, United Kingdom, Brazil, Germany, Paraguay
-
Amicus TherapeuticsTerminatedType 1 Gaucher DiseaseUnited States, United Kingdom
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited Kingdom, Israel, South Africa, United States
-
SanofiRecruitingGaucher's Disease Type IIIUnited States, Germany, Hungary, France, China, Japan, Canada, Argentina, Italy, Turkey
-
Prevail TherapeuticsEli Lilly and CompanyActive, not recruitingGaucher Disease, Type 2United States, United Kingdom
-
Idorsia Pharmaceuticals Ltd.CompletedGM2 Gangliosidosis | GM1 Gangliosidosis | Tay-Sachs Disease | Sandhoff Disease | Gaucher Disease, Type 2 | AB Variant Gangliosidosis GM2United States, Spain, Germany, Italy, Belgium, Brazil, France, Portugal, Switzerland, United Kingdom
-
Baylor Research InstituteTexas Scottish Rite Hospital for ChildrenWithdrawnGaucher Disease Type 1 | Gaucher Disease Type 3United States
-
University of ReadingRecruiting
-
National Institute of Neurological Disorders and...CompletedGaucher DiseaseUnited States, United Kingdom
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited States
-
University of ManchesterNational Health Service, United KingdomTerminatedClass II Division 1 MalocclusionUnited Kingdom
-
ShireCompletedGaucher DiseaseUnited States, Spain, United Kingdom, Israel
-
ShireCompletedGaucher Disease, Type 1Spain, Israel, United States, India, Paraguay, United Kingdom, Russian Federation, Tunisia, Argentina
-
Northumbria UniversityUnknownGlucose Metabolism Disorders | Metabolic Diseases | Type II Diabetes MellitusUnited Kingdom
-
MedImmune LLCCompletedObesity | Diabetes Mellitus, Type IIUnited Kingdom
-
ShireCompletedGaucher DiseaseUnited States, Israel, United Kingdom, Poland, Spain
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1United States, United Kingdom, Bulgaria, Canada, Colombia, India, Israel, Lebanon, Mexico, Russian Federation, Serbia, Tunisia
-
ActelionCompletedGaucher Disease Type 1United States, Taiwan, Canada, Spain, Australia, France, Brazil, Hungary, Czechia, Germany, Italy, Netherlands, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1 | Cerebroside Lipidosis Syndrome | Glucocerebrosidase Deficiency Disease | Glucosylceramide Beta-Glucosidase Deficiency Disease | Gaucher Disease, Non-Neuronopathic FormUnited States, United Kingdom, Spain, Italy, Brazil, Canada, Poland
-
ShireCompletedGaucher Disease, Type 1United States, Israel, Argentina, India, Korea, Republic of, Paraguay, Poland, Russian Federation, Spain, Tunisia, United Kingdom
-
The Christie NHS Foundation TrustUniversity of Liverpool; University of Manchester; Manchester Academic Health...TerminatedMelanoma (Skin) | Melanoma, Stage IIUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1United States, France, Germany, Italy, Brazil, Australia, Argentina, Canada, Egypt, Russian Federation, Spain, United Kingdom
-
Oxford University Hospitals NHS TrustUniversity of Oxford; Barts & The London NHS Trust; Ninewells HospitalCompletedMelanoma Stage III | Melanoma, Stage II | Melanoma, Stage IUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II)United States, Russian Federation, United Kingdom, Bulgaria, India, Ukraine
-
University of NottinghamUniversity College, London; Newcastle University; University of ManchesterUnknownFamilial HypercholesterolemiaUnited Kingdom
-
Imperial College LondonRecruitingFamilial HypercholesterolemiaUnited Kingdom
-
University of BirminghamUnknownMalocclusion, Angle Class IIUnited Kingdom
-
Queen Mary University of LondonNational Health Service, United KingdomUnknownClass II Division 1 MalocclusionUnited Kingdom
-
NHS TaysideUniversity of DundeeCompletedIncreased OverbiteUnited Kingdom
-
Chesterfield and North Derbyshire Royal HospitalCompletedChesterfield Micro-implant Study Involving Three Types of Anchorage Methods in Orthodontics (PJSPhD)Malocclusion | Class II Buccal Segment RelationshipUnited Kingdom
-
University College London HospitalsCompletedDistal Hereditary Motor Neuropathy, Type II | Distal Hereditary Motor Neuropathy, Type V | Distal Hereditary Motor Neuronopathy Type I | Distal Hereditary Motor Neuronopathy Type VIUnited Kingdom
-
University of MinnesotaRecruitingGaucher Disease, Type 3United States
-
PfizerWithdrawnType 1 Gaucher DiseaseUnited States
-
National Institute of Neurological Disorders and...CompletedType 2 Gaucher DiseaseUnited States
-
Genzyme, a Sanofi CompanyWithdrawnGaucher Disease, Type 1United States, India
-
Genzyme, a Sanofi CompanyCompletedCerebroside Lipidosis Syndrome | Glucosylceramide Beta-Glucosidase Deficiency Disease | Gaucher Disease Type I | Clucocerebrosidase Deficiency Disease | Gaucher Disease, Non-Neuronopathic FormUnited States
-
pico-tesla Magnetic Therapies, LLCCompletedType II Diabetes MellitusUnited States
-
Exsar CorporationSuspendedType I Gaucher DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II) | Acid Maltase DeficiencyUnited States, Belgium, Denmark, France, Germany, Netherlands, United Kingdom
-
MedImmune LLCCompletedRenal Insufficiency | Type II Diabetes MellitusUnited Kingdom, Germany
-
University Research Foundation for Lysosomal Storage...University of PittsburghCompletedGaucher DiseaseUnited States
-
University College, LondonUnknown
-
SanofiCompletedGaucher's DiseaseUnited States
-
Lysosomal and Rare Disorders Research and Treatment...UnknownGaucher Disease Type 1United States
-
Prevail TherapeuticsEli Lilly and CompanyRecruitingGaucher Disease | Gaucher Disease, Type 1United States, Spain, Germany